CClinicalTrials.gg
Active, not recruitingNCT03610451Updated Oct 5, 2023

Floatation-REST and Anorexia Nervosa

An interventional study of Floatation-REST plus usual care and Usual care in Anorexia Nervosa, sponsored by Laureate Institute for Brain Research, Inc.. Active, not recruiting at 1 site in United States. Open to female participants aged 13 Years to 64 Years. Per ClinicalTrials.gov, last updated 2023-10-05.

Sponsored by Laureate Institute for Brain Research, Inc. · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
68
Allocation
Randomized
Ages
13 Years to 64 Years
Sex
Female
01

Study summary

The study proposed in this protocol aims to document the effect of Floatation-REST (reduced environmental stimulation therapy) on symptoms of anorexia nervosa.

Read the detailed description

Flotation-REST (reduced environmental stimulation therapy) alters the balance of sensory input by systematically attenuating signals from the visual, auditory, thermal, tactile, vestibular, and proprioceptive systems. Previous research has shown that this heightens interoceptive awareness and reduces anxiety in clinically anxious populations. Anorexia nervosa (AN) is characterized by elevated anxiety, distorted body image, and disrupted interoception, raising the question of whether floatation therapy might positively impact these symptoms. A recent safety study found that Floatation-REST was well tolerated by individuals weight-restored outpatients with current or prior AN. Additionally, participants reported improvements in affective state and body image disturbance following floating, raising the possibility that this intervention might be investigated for clinical benefit in more acutely ill cases.

The primary aim of this study is to begin to examine the effect of Floatation-REST on body image disturbance in inpatients with AN. Secondary aims including determining whether Floatation-REST has an impact on anxiety, emotional distress, eating disorder severity, functional ability, and interoception.

02

Conditions studied

  • Anorexia Nervosa

Keywords

  • Anorexia nervosa
  • Floatation therapy
03

In context

Anorexia

411 studies on the registry are indexed under Anorexia; 67 are open to participants now.

This study's enrollment of 68 is above the median of 41 across 287 interventional studies indexed under Anorexia.

Browse Anorexia studies →

Lead sponsor

Laureate Institute for Brain Research, Inc. is the lead sponsor of 53 studies on the registry; 12 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
13 Years to 64 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Primary clinical diagnosis of anorexia nervosa
  • Receiving inpatient treatment for eating disorder
  • Body mass index greater than or equal to 16
  • No new medication prescription in the week prior to study randomization
  • Independently ambulatory
  • No current evidence of orthostatic hypotension
  • Ability to lay flat comfortably
  • Possession of a smartphone with data plan
  • English proficiency

Exclusion criteria

Exclusion Criteria:

  • Active suicidal ideation
  • Active cutting or skin lacerating behaviors
  • Orthostatic hypotension (defined as a drop of ≥ 20 mm Hg in systolic BP or a drop of ≥ 10 mm Hg in diastolic BP when measured shortly after transitioning from lying down to standing)
  • Comorbid schizophrenia spectrum or other psychotic disorder
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
68 participants (actual)

Study arms

  • Experimental
    Floatation-REST

    Participants will float supine in a pool of water saturated with epsom salt, in a light and sound attenuated chamber, for up to 60 minutes, on 8 separate occasions. Ratings of the experience will be collected before and after each float.

    Behavioral: Floatation-REST plus usual care

  • Other
    Usual care

    Participants will be assessed along the same time periods, i.e., before and after a 60 minute window, on 8 separate occasions. Ratings of the experience will be collected before and after each time period.

    Behavioral: Usual care

Interventions

  • BehavioralFloatation-REST plus usual care

    Individuals will receive Floatation-REST plus usual care. Floating creates an environment with minimal visual, auditory, tactile, proprioceptive, and thermal input to the brain. The float rooms are lightproof and soundproof. A high concentration Epsom salt water solution allows individuals to effortlessly float on their back while remaining completely still, reducing both proprioceptive and tactile input to the brain. The temperature of the water is calibrated to the temperature of the skin (\~94° F) and the temperature of the air is calibrated to the temperature of the water, making it difficult to discern the boundary between air and water, thus reducing thermal input to the brain while minimizing the need for thermoregulation of the skin.

  • BehavioralUsual care

    Individuals will receive usual care on the inpatient unit of the Laureate Eating Disorders Program.

06

What researchers measure

Primary outcomes

  1. Body image dissatisfaction score on the Photographic Figure Rating Scale

    Average of the absolute change in body image dissatisfaction from pre to post float across all eight floats (score range: 0 to 10; larger changes indicate greater severity of body image dissatisfaction)

    Time frame: Through study completion, an average of 1 year

Secondary outcomes

  1. Anxiety on the Spielberger State Trait Anxiety Inventory

    Average of the change in anxiety rating from pre to post float across all eight float (range 20 to 80, higher scores indicate greater severity of anxiety)

    Time frame: Through study completion, an average of 1 year

  2. Anxiety on the NIH Promis Anxiety Scale

    Average of the change in anxiety rating from pre to post float across all eight float (range 6 to 30, higher scores indicate greater severity of anxiety)

    Time frame: Through study completion, an average of 1 year

  3. Anxiety sensitivity on the Anxiety Sensitivity Index-3R

    Change in anxiety sensitivity after the final float relative to baseline (range 0 to 96, higher scores indicate greater severity of anxiety sensitivity)

    Time frame: Through study completion, an average of 1 year

  4. Eating disorder severity on the Eating Disorder Examination Questionnaire

    Change in eating disorder severity after the final float relative to baseline (range 0 to 6, larger scores indicate greater severity of eating disorder)

    Time frame: Through study completion, an average of 1 year

  5. Functional ability on the Sheehan Disability Questionnaire

    Change in functional ability after the final float relative to baseline (range 0 to 30, higher scores indicate greater severity of disability)

    Time frame: Through study completion, an average of 1 year

  6. Body image disturbance on the Body Image States Scale

    Change in body image disturbance after the final float relative to baseline (range 0 to 48, higher scores indicate greater severity of body image disturbance)

    Time frame: Through study completion, an average of 1 year

  7. Interoceptive self report on the Multidimensional Interoceptive Awareness Scale

    Change in total interoceptive awareness score after the final float relative to baseline (range 0 to 160, higher scores indicating greater interoceptive awareness)

    Time frame: Through study completion, an average of 1 year

  8. Body image disturbance on the Body Appreciation Scale-2

    Change in body image disturbance score after the final float relative to baseline (range 10 to 50, higher scores indicating reduced severity of body image disturbance)

    Time frame: Through study completion, an average of 1 year

07

Study locations

1 site
  • Laureate Institute for Brain Research
    Tulsa, Oklahoma 74136, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 5, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03610451
Lead sponsor
Laureate Institute for Brain Research, Inc.
Responsible party
Sponsor
First posted
Aug 1, 2018
Start date
Mar 16, 2018
Primary completion
Mar 1, 2022
Completion
Oct 2024 (estimated)
Last update
Oct 5, 2023

Study contacts

Sahib Khalsa, MD, PhD
principal investigator · Laureate Institute for Brain Research

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Oct 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion